Invention Grant
- Patent Title: Heterocyclic compounds as PI3K-γ inhibitors
-
Application No.: US15343375Application Date: 2016-11-04
-
Publication No.: US10065963B2Publication Date: 2018-09-04
- Inventor: Artem Shvartsbart , Stacey Shepard , Andrew P. Combs , Lixin Shao , Nikoo Falahatpisheh , Ge Zou , Eddy W. Yue , Ravi Kumar Jalluri
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519 ; C07D519/00 ; A61P35/00 ; A61P9/00 ; A61P25/28 ; A61P29/00
Abstract:
This application relates to compounds of Formula (I): or pharmaceutically acceptable salts or stereoisomers thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.
Public/Granted literature
- US20170129899A1 HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS Public/Granted day:2017-05-11
Information query
